The Oncology Institute, Inc. (TOI) Stock Grade

About The Oncology Institute, Inc.'s fundamentals

The Oncology Institute is a healthcare company with a market capitalization of $512.9 million that has demonstrated strong top-line expansion, with revenue growing 27.8% year-over-year. However, the company is currently unprofitable, reporting a net loss in its latest annual statement and operating at a negative net margin of -12.1%. The company does not pay a dividend and does not have a meaningful P/E ratio due to its loss-making status. The elevated return on equity figure of 385.5% reflects the company's small equity base rather than operational profitability.